ATVB:睾酮转化成雌激素和雄激素衍生物预防男性皮肤缺血坏死

2017-04-16 MedSci MedSci原创

慢性不愈合伤是一个重大医疗问题,与疾病发病率和死亡率相关,因此迫切需要新的治疗策略。考虑性别差异是这一领域迈向个体/精准医学的第一步。缺血削弱受伤的伤口愈合,之前研究证明17β-雌二醇显着防止雌性小鼠缺血诱导的皮瓣坏死。然而,雄性小鼠中睾丸激素的这一领域作用尚未报道。本研究我们使用皮瓣缺血模型研究了雄性小鼠中类固醇激素的作用。去势的雄性小鼠缺血后发生皮肤坏死,而给予睾酮治疗同等保护完整或去势雄性小

慢性不愈合伤是一个重大医疗问题,与疾病发病率和死亡率相关,因此迫切需要新的治疗策略。考虑性别差异是这一领域迈向个体/精准医学的第一步。缺血削弱受伤的伤口愈合,之前研究证明17β-雌二醇显着防止雌性小鼠缺血诱导的皮瓣坏死。然而,雄性小鼠中睾丸激素的这一领域作用尚未报道。本研究我们使用皮瓣缺血模型研究了雄性小鼠中类固醇激素的作用。

去势的雄性小鼠缺血后发生皮肤坏死,而给予睾酮治疗同等保护完整或去势雄性小鼠。睾酮可以(1)芳构化为17β-雌二醇后激活雌激素受体,或(2)还原成二氢睾酮,其是激活雄激素受体的非可变性雄激素。本研究发现二氢睾酮通过促进皮肤血运重建来保护阉割的WT小鼠,使用流动介导的外向重塑互补模型证明这一过程可能是通过直接作用在阻力血管。给予阉割的雄性小鼠17β-雌二醇治疗可以激活雌激素受体-α增加皮肤血运重建和皮肤存活,显着保护它们免于缺血坏死。值得注意的是,相比于二氢睾酮,17β-雌二醇改善皮肤存活的效率较高。

睾酮为男性提供强有力的保护,防止皮肤坏死,并通过其雌激素和雄激素衍生物起作用,对皮肤存活和血运重建具有保护作用。

原始出处:Chenu C, Adlanmerini M, et al. Testosterone Prevents Cutaneous Ischemia and Necrosis in Males Through Complementary Estrogenic and Androgenic Actions.Arterioscler Thromb Vasc Biol. 2017 Mar 30. pii: ATVBAHA.117.309219.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1812653, encodeId=4a871812653ae, content=<a href='/topic/show?id=d193900940b' target=_blank style='color:#2F92EE;'>#衍生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90094, encryptionId=d193900940b, topicName=衍生物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jan 04 21:00:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805946, encodeId=0549180594661, content=<a href='/topic/show?id=99fbe93492d' target=_blank style='color:#2F92EE;'>#缺血坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79349, encryptionId=99fbe93492d, topicName=缺血坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Oct 29 07:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977949, encodeId=b3e619e79492a, content=<a href='/topic/show?id=20411e958de' target=_blank style='color:#2F92EE;'>#TVB#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17958, encryptionId=20411e958de, topicName=TVB)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a5a149, createdName=gongliu, createdTime=Fri Nov 03 07:00:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800241, encodeId=04e618002413b, content=<a href='/topic/show?id=0414e2099b0' target=_blank style='color:#2F92EE;'>#皮肤缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72099, encryptionId=0414e2099b0, topicName=皮肤缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Mon May 22 12:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188332, encodeId=f968188332f8, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Apr 17 23:17:09 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362823, encodeId=13ad136282317, content=<a href='/topic/show?id=b723414321c' target=_blank style='color:#2F92EE;'>#坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41432, encryptionId=b723414321c, topicName=坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Mon Apr 17 15:00:00 CST 2017, time=2017-04-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1812653, encodeId=4a871812653ae, content=<a href='/topic/show?id=d193900940b' target=_blank style='color:#2F92EE;'>#衍生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90094, encryptionId=d193900940b, topicName=衍生物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jan 04 21:00:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805946, encodeId=0549180594661, content=<a href='/topic/show?id=99fbe93492d' target=_blank style='color:#2F92EE;'>#缺血坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79349, encryptionId=99fbe93492d, topicName=缺血坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Oct 29 07:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977949, encodeId=b3e619e79492a, content=<a href='/topic/show?id=20411e958de' target=_blank style='color:#2F92EE;'>#TVB#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17958, encryptionId=20411e958de, topicName=TVB)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a5a149, createdName=gongliu, createdTime=Fri Nov 03 07:00:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800241, encodeId=04e618002413b, content=<a href='/topic/show?id=0414e2099b0' target=_blank style='color:#2F92EE;'>#皮肤缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72099, encryptionId=0414e2099b0, topicName=皮肤缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Mon May 22 12:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188332, encodeId=f968188332f8, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Apr 17 23:17:09 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362823, encodeId=13ad136282317, content=<a href='/topic/show?id=b723414321c' target=_blank style='color:#2F92EE;'>#坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41432, encryptionId=b723414321c, topicName=坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Mon Apr 17 15:00:00 CST 2017, time=2017-04-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1812653, encodeId=4a871812653ae, content=<a href='/topic/show?id=d193900940b' target=_blank style='color:#2F92EE;'>#衍生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90094, encryptionId=d193900940b, topicName=衍生物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jan 04 21:00:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805946, encodeId=0549180594661, content=<a href='/topic/show?id=99fbe93492d' target=_blank style='color:#2F92EE;'>#缺血坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79349, encryptionId=99fbe93492d, topicName=缺血坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Oct 29 07:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977949, encodeId=b3e619e79492a, content=<a href='/topic/show?id=20411e958de' target=_blank style='color:#2F92EE;'>#TVB#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17958, encryptionId=20411e958de, topicName=TVB)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a5a149, createdName=gongliu, createdTime=Fri Nov 03 07:00:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800241, encodeId=04e618002413b, content=<a href='/topic/show?id=0414e2099b0' target=_blank style='color:#2F92EE;'>#皮肤缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72099, encryptionId=0414e2099b0, topicName=皮肤缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Mon May 22 12:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188332, encodeId=f968188332f8, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Apr 17 23:17:09 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362823, encodeId=13ad136282317, content=<a href='/topic/show?id=b723414321c' target=_blank style='color:#2F92EE;'>#坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41432, encryptionId=b723414321c, topicName=坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Mon Apr 17 15:00:00 CST 2017, time=2017-04-17, status=1, ipAttribution=)]
    2017-11-03 gongliu
  4. [GetPortalCommentsPageByObjectIdResponse(id=1812653, encodeId=4a871812653ae, content=<a href='/topic/show?id=d193900940b' target=_blank style='color:#2F92EE;'>#衍生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90094, encryptionId=d193900940b, topicName=衍生物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jan 04 21:00:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805946, encodeId=0549180594661, content=<a href='/topic/show?id=99fbe93492d' target=_blank style='color:#2F92EE;'>#缺血坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79349, encryptionId=99fbe93492d, topicName=缺血坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Oct 29 07:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977949, encodeId=b3e619e79492a, content=<a href='/topic/show?id=20411e958de' target=_blank style='color:#2F92EE;'>#TVB#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17958, encryptionId=20411e958de, topicName=TVB)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a5a149, createdName=gongliu, createdTime=Fri Nov 03 07:00:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800241, encodeId=04e618002413b, content=<a href='/topic/show?id=0414e2099b0' target=_blank style='color:#2F92EE;'>#皮肤缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72099, encryptionId=0414e2099b0, topicName=皮肤缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Mon May 22 12:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188332, encodeId=f968188332f8, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Apr 17 23:17:09 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362823, encodeId=13ad136282317, content=<a href='/topic/show?id=b723414321c' target=_blank style='color:#2F92EE;'>#坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41432, encryptionId=b723414321c, topicName=坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Mon Apr 17 15:00:00 CST 2017, time=2017-04-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1812653, encodeId=4a871812653ae, content=<a href='/topic/show?id=d193900940b' target=_blank style='color:#2F92EE;'>#衍生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90094, encryptionId=d193900940b, topicName=衍生物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jan 04 21:00:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805946, encodeId=0549180594661, content=<a href='/topic/show?id=99fbe93492d' target=_blank style='color:#2F92EE;'>#缺血坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79349, encryptionId=99fbe93492d, topicName=缺血坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Oct 29 07:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977949, encodeId=b3e619e79492a, content=<a href='/topic/show?id=20411e958de' target=_blank style='color:#2F92EE;'>#TVB#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17958, encryptionId=20411e958de, topicName=TVB)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a5a149, createdName=gongliu, createdTime=Fri Nov 03 07:00:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800241, encodeId=04e618002413b, content=<a href='/topic/show?id=0414e2099b0' target=_blank style='color:#2F92EE;'>#皮肤缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72099, encryptionId=0414e2099b0, topicName=皮肤缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Mon May 22 12:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188332, encodeId=f968188332f8, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Apr 17 23:17:09 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362823, encodeId=13ad136282317, content=<a href='/topic/show?id=b723414321c' target=_blank style='color:#2F92EE;'>#坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41432, encryptionId=b723414321c, topicName=坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Mon Apr 17 15:00:00 CST 2017, time=2017-04-17, status=1, ipAttribution=)]
    2017-04-17 虈亣靌

    感谢分享,学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1812653, encodeId=4a871812653ae, content=<a href='/topic/show?id=d193900940b' target=_blank style='color:#2F92EE;'>#衍生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90094, encryptionId=d193900940b, topicName=衍生物)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jan 04 21:00:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805946, encodeId=0549180594661, content=<a href='/topic/show?id=99fbe93492d' target=_blank style='color:#2F92EE;'>#缺血坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79349, encryptionId=99fbe93492d, topicName=缺血坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Oct 29 07:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977949, encodeId=b3e619e79492a, content=<a href='/topic/show?id=20411e958de' target=_blank style='color:#2F92EE;'>#TVB#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17958, encryptionId=20411e958de, topicName=TVB)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a5a149, createdName=gongliu, createdTime=Fri Nov 03 07:00:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800241, encodeId=04e618002413b, content=<a href='/topic/show?id=0414e2099b0' target=_blank style='color:#2F92EE;'>#皮肤缺血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72099, encryptionId=0414e2099b0, topicName=皮肤缺血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Mon May 22 12:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188332, encodeId=f968188332f8, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Apr 17 23:17:09 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362823, encodeId=13ad136282317, content=<a href='/topic/show?id=b723414321c' target=_blank style='color:#2F92EE;'>#坏死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41432, encryptionId=b723414321c, topicName=坏死)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Mon Apr 17 15:00:00 CST 2017, time=2017-04-17, status=1, ipAttribution=)]
    2017-04-17 millore

相关资讯

J Clin Endocrinol Metab:孕激素和睾酮联合注射可有效用于男性避孕

目前,仍未有一种安全有效的可逆性男性避孕方法。本研究旨在评估联用孕激素和睾酮注射抑制精子发生和避孕保护的效果。 采用前瞻性多中心研究设计,在十个研究中心,纳入18-45岁的健康男性,以及其18-38岁的女性伴侣,均无生育问题。 对男性参与者进行肌内注射庚酸炔诺酮200毫克和1000毫克睾酮,每8周给药一次。然后通过精液分析精子发生的抑制作用,通过妊娠率来评估避孕保护效果。 结果,

Hypertension:睾酮通过上调miR-22抑制雌激素信号

该研究的结果揭示了在人胎盘中miR-22调节雄激素和雌激素平衡生产的潜在机制,并从调节内分泌的角度为子痫前期的发病机制提供了新的见解。

盘点:除了影响性功能,睾酮还会影响糖尿病的发生

睾酮是人体主要的循环雄激素,与性别分化、生长以及维持生殖功能、第二性征和性欲有关。男性一旦进入三十岁之后,睾酮水平便开始下降,正常情况下每年下降约1%左右。这里梅斯小编整理了关于睾酮的一些研究供大家了解。【1】低睾酮水平可能是2型糖尿病的危险标志近期发表在The Journal of Clinical Endocrinology & Metabolism的研究称,睾酮水平低可能是2型糖

BMJ:睾酮治疗与静脉血栓栓塞风险增加有关

由此可见,开始睾酮治疗与静脉血栓栓塞的风险增加有关,并在六个月内达到高峰,此后下降。

BMC MED:睾酮治疗会对男性节食减肥产生什么影响?

对于节食减肥的肥胖男性,如果加入睾酮治疗,会对减肥效果产生什么影响呢? 我们在一个三级转诊中心进行了一项随机双盲、平行、安慰剂对照试验。共纳入了100名肥胖男性(BMI ≥ 30 kg/m2),总睾酮水平低于12 nmol/L的,中位数年龄53年(四分位距为47–60),接受长达10周的极低能量饮食(VLED),随后体重维持46周。将这些患者随机分到每周肌肉注射十一酸睾酮,进行10周(n=4

天哪!真的可以从手指长度来看大脑功能

近日,据发表于Behavioural Brain Research的一项新的研究探究了手指长度与大脑工作之间的关联。总所周知,子宫内睾酮的水平可影响胎儿成年后的手指长度。与无名指相比,食指长度较短说明其胎儿期其母体子宫内的睾酮水平较高,而食指长度较长说明睾酮水平较低。研究共纳入了42名女性,测量其手指长度,对21名女性给予一滴睾酮,另外21名女性作为对照组给予安慰剂。之后所有研究对象处理多种心理问